| |
| |
|
| Insider
Information: |
Pernock David |
| Relationship: |
Pres & Chief Operating... |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
160,225 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$542,984 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
160,225 |
|
|
| Total
Value |
$542,984 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrocell Science Inc |
FCSC |
Chairman and CEO, Dire... |
2016-12-02 |
105,600 |
2013-11-21 |
0 |
Premium* |
|
|
Eagle Pharmaceuticals, Inc. |
EGRX |
Pres & Chief Operating... |
2021-02-02 |
54,625 |
2017-03-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGRX |
Eagle Pharmaceuticals, In... |
Pres & Chief Operating Officer |
• – – |
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,700 |
54,625 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres & Chief Operating Officer |
• – – |
2021-01-23 |
4 |
D |
$47.70 |
$90,248 |
D/D |
(1,892) |
44,925 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres & Chief Operating Officer |
• – – |
2021-01-07 |
4 |
D |
$50.97 |
$46,179 |
D/D |
(906) |
46,817 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres & Chief Operating Officer |
• – – |
2021-01-05 |
4 |
D |
$50.02 |
$104,442 |
D/D |
(2,088) |
47,723 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2020-01-23 |
4 |
D |
$57.98 |
$103,958 |
D/D |
(1,793) |
49,811 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2020-01-07 |
4 |
D |
$57.38 |
$51,872 |
D/D |
(904) |
51,604 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2020-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,500 |
52,508 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2019-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,900 |
31,008 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2019-01-07 |
4 |
D |
$41.33 |
$35,461 |
D/D |
(858) |
10,108 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2018-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,966 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2017-05-19 |
4 |
B |
$79.69 |
$20,321 |
D/D |
255 |
966 |
2.74 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2017-05-16 |
4 |
B |
$82.24 |
$16,448 |
D/D |
200 |
711 |
2.74 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2017-03-21 |
4 |
B |
$83.98 |
$5,123 |
D/D |
61 |
511 |
2.74 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Pres. & Chief Comm. Officer |
• – – |
2017-03-09 |
4 |
B |
$77.84 |
$35,028 |
D/D |
450 |
450 |
2.74 |
- |
|
| FCSC |
Fibrocell Science Inc |
Chairman and CEO |
• • – |
2016-12-02 |
4 |
B |
$0.92 |
$46,085 |
D/D |
50,000 |
105,600 |
2.81 |
- |
|
| FCSC |
Fibrocell Science Inc |
Chairman and CEO |
• • – |
2015-11-13 |
4 |
B |
$5.00 |
$14,997 |
D/D |
3,000 |
55,600 |
2.81 |
- |
|
| FCSC |
Fibrocell Science Inc |
Chairman and CEO |
• • – |
2015-08-11 |
4 |
B |
$6.54 |
$22,890 |
D/D |
3,500 |
52,600 |
2.81 |
- |
|
| FCSC |
Fibrocell Science Inc |
Chairman and CEO |
• • – |
2014-12-12 |
4 |
B |
$2.52 |
$12,600 |
D/D |
5,000 |
32,500 |
2.81 |
- |
|
| FCSC |
Fibrocell Science Inc |
Chairman and CEO |
• • – |
2014-11-20 |
4 |
B |
$2.54 |
$12,686 |
D/D |
5,000 |
27,500 |
2.81 |
- |
|
| FCSC |
Fibrocell Science Inc |
Chief Executive Officer |
• • – |
2014-06-05 |
4 |
B |
$2.95 |
$36,925 |
D/D |
12,500 |
22,500 |
2.81 |
- |
|
| FCSC |
Fibrocell Science Inc |
Chief Executive Officer |
• • – |
2013-11-21 |
4 |
B |
$3.69 |
$36,900 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
